This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Find weekend side hustles that pay well while offering the flexibility you need. These gigs can significantly boost your income.
19,264 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Trinidad and Tobago signed two memorandums of understanding with U.S. firms to move forward with large-scale data cen...
DraftKings posted strong top-line growth yet issued cautious guidance, sending its stock lower. This analysis breaks ...
Dycom Industries sits at the center of the U.S. buildout wave. This article breaks down the 2026 earnings outlook, ke...
Sheryl Sandberg delivers a blunt critique of Silicon Valley's workplace climate, calling hypermasculine rhetoric amon...
Savvy savers in their 40s are increasingly splitting 401K contributions between traditional and Roth accounts to bala...
This article breaks down egain (egan) 2026 earnings with a clear, data-driven view. We examine revenue drivers, margi...
A famous call for authenticity in a world of celebrity buzz has real money lessons. Discover how Cynthia Erivo's blun...
Tilray shifted from cannabis focus to a BrewDog partnership in search of diversification. But early UK sales data rai...
Gen Z is departing San Francisco for Texas and Florida, triggering a new wave where welcomer cities like Nashville an...
One hidden nuclear-energy stock connected to the space economy could be a game changer. This article explains how it ...
Lincoln Financial is positioned as a stable anchor for retirement, while three Miller-style bets—Strategy, Nabors, an...